These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 14754978)

  • 1. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany.
    König HH; Barry JC
    Pediatrics; 2004 Feb; 113(2):e95-108. PubMed ID: 14754978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model.
    König HH; Barry JC
    Br J Ophthalmol; 2004 May; 88(5):606-12. PubMed ID: 15090409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of orthoptic screening in kindergarten: a decision-analytic model.
    König HH; Barry JC; Leidl R; Zrenner E
    Strabismus; 2000 Jun; 8(2):79-90. PubMed ID: 10980689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost effectiveness of mass orthoptic screening in kindergarten for early detection of developmental vision disorders].
    König HH; Barry JC; Leidl R; Zrenner E
    Gesundheitswesen; 2000 Apr; 62(4):196-206. PubMed ID: 10844816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of orthoptic screening: results of a field study in 121 German kindergartens.
    König HH; Barry JC; Leidl R; Zrenner E
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3209-15. PubMed ID: 12356826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness of screening for amblyopia].
    Neubauer AS; Neubauer S
    Klin Monbl Augenheilkd; 2005 Feb; 222(2):110-6. PubMed ID: 15719314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valuing vision.
    Kemper AR
    Pediatrics; 2004 Feb; 113(2):404-5. PubMed ID: 14754958
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost effectiveness of the determination of autoantibodies against cyclic citrullinated peptide in the early diagnosis of rheumatoid arthritis.
    Konnopka A; Conrad K; Baerwald C; König HH
    Ann Rheum Dis; 2008 Oct; 67(10):1399-405. PubMed ID: 18192304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation.
    Carlton J; Karnon J; Czoski-Murray C; Smith KJ; Marr J
    Health Technol Assess; 2008 Jun; 12(25):iii, xi-194. PubMed ID: 18513466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of different methods of screening for amblyopia in kindergarten.
    König HH; Barry JC
    Pediatrics; 2002 Apr; 109(4):e59. PubMed ID: 11927732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential cost-effectiveness of amblyopia screening programs.
    Rein DB; Wittenborn JS; Zhang X; Song M; Saaddine JB;
    J Pediatr Ophthalmol Strabismus; 2012; 49(3):146-55; quiz 145, 156. PubMed ID: 21877675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
    McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A
    Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening for amblyopia among kindergarten children in China.
    Gu YT; Shi B; Li DL; Zhang TT; Wang P; Jiang J; Pan CW
    Prev Med Rep; 2024 Mar; 39():102662. PubMed ID: 38426040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach.
    Hofer F; Kauczor HU; Stargardt T
    Lung Cancer; 2018 Oct; 124():189-198. PubMed ID: 30268459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-utility analysis of therapy for amblyopia.
    Membreno JH; Brown MM; Brown GC; Sharma S; Beauchamp GR
    Ophthalmology; 2002 Dec; 109(12):2265-71. PubMed ID: 12466169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
    Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
    J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening individuals with intracranial aneurysms for abdominal aortic aneurysms is cost-effective based on estimated coprevalence.
    Ball BZ; Jiang B; Mehndiratta P; Stukenborg GJ; Upchurch GR; Meschia JF; Worrall BB; Southerland AM
    J Vasc Surg; 2016 Sep; 64(3):811-818.e3. PubMed ID: 27565600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness model of screening strategies for amblyopia and risk factors and its application in a german setting.
    Gandjour A; Schlichtherle S; Neugebauer A; Rüssmann W; Lauterbach KW
    Optom Vis Sci; 2003 Mar; 80(3):259-69. PubMed ID: 12637838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
    Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.